LTFS
ANTH

Ladenburg Thalmann Financial Services’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,500
Closed – – 5504
2018
Q2 		$0 Hold
1,500
– – ﹤0.01% 5218
2018
Q1 		$0 Hold
1,500
– – ﹤0.01% 5307
2017
Q4 		$2K Hold
1,500
– – ﹤0.01% 4849
2017
Q3 		$2K Hold
1,500
– – ﹤0.01% 4741
2017
Q2 		$2K Hold
1,500
– – ﹤0.01% 4672
2017
Q1 		$5K Buy
+1,500
New +$7.09K ﹤0.01% 4350

Other funds holding ANTH

VCM
Vigilant Capital Management Portland, Maine $1.34B AUM 15.33% 1-Year Est. Return

Ladenburg Thalmann Financial Services's ANTH Position: Q3 2018 in Review

Ladenburg Thalmann Financial Services sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q3 2018, closing a stake of 1,500 shares.

Ladenburg Thalmann Financial Services first reported a position in ANTH in Q1 2017 and held it in 6 quarters. The position peaked at $5K in Q1 2017. 1 fund tracked by Wall St. Rank holds ANTH as of Q3 2018.

  • Ladenburg Thalmann Financial Services reported no remaining Anthera Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 1,500 Anthera Pharmaceuticals, Inc. shares in Q3 2018.
  • Ladenburg Thalmann Financial Services first reported a position in Anthera Pharmaceuticals, Inc. in Q1 2017 and held it in 6 quarters.
  • Ladenburg Thalmann Financial Services's Anthera Pharmaceuticals, Inc. position peaked at $5K in Q1 2017.
  • 1 fund tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q3 2018.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q3 2018, filed 14 Nov 2018.